Gene · 990
Papers3,285
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 3,285
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The transmembrane proteins (TMEM) and their role in cell proliferation, migration, invasion, and epithelial-mesenchymal transition in cancer. | Front Oncol | 2023 | 37936608 | PubTator, text mining | PubMed |
| EMP3 sustains oncogenic EGFR/CDK2 signaling by restricting receptor degradation in glioblastoma. | Acta Neuropathol Commun | 2023 | 37936247 | PubTator, text mining | PubMed |
| A systematic framework for identifying prognostic necroptosis-related lncRNAs and verification of lncRNA CRNDE/miR-23b-3p/IDH1 regulatory axis in glioma. | Aging (Albany NY) | 2023 | 37934582 | PubTator, text mining | PubMed |
| PPARG is a potential target of Tanshinone IIA in prostate cancer treatment: a combination study of molecular docking and dynamic simulation based on transcriptomic bioinformatics. | Eur J Med Res | 2023 | 37932808 | PubTator, text mining | PubMed |
| The mitotic cell cycle-associated nomogram predicts overall survival in lung adenocarcinoma. | Cancer Med | 2023 | 37930238 | PubTator, text mining | PubMed |
Computational identification and clinical validation of a novel risk signature based on coagulation-related lncRNAs for predicting prognosis, immunotherapy response, and chemosensitivity in colorectal cancer patients. | Front Immunol | 2023 | 37928532 | PubTator, text mining | PubMed |
| Kinome profiling identifies MARK3 and STK10 as potential therapeutic targets in uveal melanoma. | J Biol Chem | 2023 | 37923138 | PubTator, text mining | PubMed |
| The Evaluation of Prognostic Value and Immune Characteristics of Ferroptosis-Related Genes in Lung Squamous Cell Carcinoma. | Glob Med Genet | 2023 | 37915460 | PubTator, text mining | PubMed |
| High-risk histological subtype-related FAM83A hijacked FOXM1 transcriptional regulation to promote malignant progression in lung adenocarcinoma. | PeerJ | 2023 | 37904848 | PubTator, text mining | PubMed |
| Prognostic model of hepatocellular carcinoma based on cancer grade. | World J Clin Cases | 2023 | 37900243 | PubTator, text mining | PubMed |
| Engineered Extracellular Vesicles: Emerging Therapeutic Strategies for Translational Applications. | Int J Mol Sci | 2023 | 37894887 | PubTator, text mining | PubMed |
| Role of TOP2A and CDC6 in liver cancer. | Medicine (Baltimore) | 2023 | 37861550 | PubTator, text mining | PubMed |
| Comparison of cell response to chromatin and DNA damage. | Nucleic Acids Res | 2023 | 37855682 | PubTator, text mining | PubMed |
| Ligand-dependent hedgehog signaling maintains an undifferentiated, malignant osteosarcoma phenotype. | Oncogene | 2023 | 37845394 | PubTator, text mining | PubMed |
| Identification of NCAPG as an Essential Gene for Neuroblastoma Employing CRISPR-Cas9 Screening Database and Experimental Verification. | Int J Mol Sci | 2023 | 37834394 | PubTator, text mining | PubMed |
| Prostate Cancer Stem Cells: Biology and Treatment Implications. | Int J Mol Sci | 2023 | 37834336 | PubTator, text mining | PubMed |
| The Cytoprotective Role of Autophagy in Response to BRAF-Targeted Therapies. | Int J Mol Sci | 2023 | 37834222 | PubTator, text mining | PubMed |
| CDC6, a key replication licensing factor, is overexpressed and confers poor prognosis in diffuse large B-cell lymphoma. | BMC Cancer | 2023 | 37833632 | PubTator, text mining | PubMed |
| Revisiting evolutionary trajectories and the organization of the Pleolipoviridae family. | PLoS Genet | 2023 | 37831715 | PubTator, text mining | PubMed |
| LncRNA LINC00667 gets involved in clear cell renal cell carcinoma development and chemoresistance by regulating the miR-143-3p/ZEB1 axis. | Aging (Albany NY) | 2023 | 37827696 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/990/papers?page=10